A Calgary-based biotech company is turning heads on Tuesday after it was announced that a recent study showed its lead drug candidate MB-204 demonstrated a 400% increase in the...

To read the full story on AllPennyStocks.com, click here.

Marvel Biosciences (TSXV:MRVL)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024 Haga Click aquí para más Gráficas Marvel Biosciences.
Marvel Biosciences (TSXV:MRVL)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024 Haga Click aquí para más Gráficas Marvel Biosciences.